Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1988-10-21
|
pubmed:abstractText |
The effect of nedocromil sodium (4 mg; 7.8 X 10(-6) M) on adenosine-induced bronchoconstriction was compared with that of a higher dose of sodium cromoglycate (10 mg; 24.1 X 10(-6) M). Eleven allergic asthmatic patients (mean age 26.28 +/- 12.21 years) were studied. Adenosine (0.03-4.00 mg) was administered as nebulized aerosol. The dose of adenosine producing a 20% change in FEV1(PD20) was calculated from the individual semi-logarithmic dose-response curves. Patients were studied on 4 separate days. On the first day the adenosine challenge was performed; on subsequent days patients were pretreated (20 min before challenge) with either placebo or test drug (nedocromil sodium 2 x 2 mg or sodium cromoglycate 2 x 5 mg) administered by pressurized aerosol in a randomized, double-blind manner. Statistical analysis was performed by two-way analysis of variance. Neither sodium cromoglycate nor nedocromil sodium showed a significant bronchodilator effect. In patients treated with placebo, inhalation of adenosine produced a dose-related bronchoconstriction with a geometric mean PD20 of 0.42 mg. After drug administration the mean PD20 values were 1.29 mg with sodium cromoglycate and 2.30 mg with nedocromil sodium. Both drugs produced a significant increase in mean PD20 value in comparison with placebo and baseline (P less than 0.01). These results demonstrate that nedocromil sodium (4 mg) is significantly more potent than a larger dose of sodium cromoglycate (10 mg) in inhibiting adenosine-induced bronchoconstriction (P less than 0.05).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adenosine,
http://linkedlifedata.com/resource/pubmed/chemical/Aerosols,
http://linkedlifedata.com/resource/pubmed/chemical/Cromolyn Sodium,
http://linkedlifedata.com/resource/pubmed/chemical/Nedocromil,
http://linkedlifedata.com/resource/pubmed/chemical/Quinolines
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0009-9090
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
367-74
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2843305-Adenosine,
pubmed-meshheading:2843305-Adolescent,
pubmed-meshheading:2843305-Adult,
pubmed-meshheading:2843305-Aerosols,
pubmed-meshheading:2843305-Airway Resistance,
pubmed-meshheading:2843305-Asthma,
pubmed-meshheading:2843305-Bronchial Provocation Tests,
pubmed-meshheading:2843305-Cromolyn Sodium,
pubmed-meshheading:2843305-Double-Blind Method,
pubmed-meshheading:2843305-Female,
pubmed-meshheading:2843305-Forced Expiratory Volume,
pubmed-meshheading:2843305-Humans,
pubmed-meshheading:2843305-Male,
pubmed-meshheading:2843305-Middle Aged,
pubmed-meshheading:2843305-Nedocromil,
pubmed-meshheading:2843305-Quinolines,
pubmed-meshheading:2843305-Random Allocation
|
pubmed:year |
1988
|
pubmed:articleTitle |
Comparative study of the effects of nedocromil sodium (4 mg) and sodium cromoglycate (10 mg) on adenosine-induced bronchoconstriction in asthmatic subjects.
|
pubmed:affiliation |
Institute of Respiratory Diseases, University of Catania, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|